| Literature DB >> 35097099 |
Ken Takami1, Tsuneaki Kenzaka2, Ayako Kumabe3, Megumi Fukuzawa4, Yoko Eto5, Shun Nakata6, Katsuhiro Shinohara6, Kazunori Endo1.
Abstract
BACKGROUND: Varicella-zoster virus (VZV) generally causes chickenpox at first infection in childhood and then establishes latent infection in the dorsal root ganglia of the spinal cord or other nerves. Virus reactivation owing to an impaired immune system causes inflammation along spinal nerves from the affected spinal segment, leading to skin manifestations (herpes zoster). Viremia and subsequent hematogenous transmission and nerve axonal transport of the virus may lead to meningitis, encephalitis, and myelitis. One such case is described in this study. CASEEntities:
Keywords: Case report; Central nervous system; Encephalitis; Meningitis; Myelitis; Varicella-zoster virus
Year: 2022 PMID: 35097099 PMCID: PMC8771392 DOI: 10.12998/wjcc.v10.i2.717
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.337
Figure 1The skin lesion on the right chest.
Figure 2Skin biopsy of the lesion on the right chest. The lesion shows intranuclear inclusion bodies and ballooning degeneration.
Results of cerebrospinal fluid analysis on admission
|
|
|
|
| Color | Light yellow | Clear |
| Xanthochromia | Positive | Negative |
| Cell count (cells/μL) | 484 | 0–3 |
| Monocyte count (cells/μL) | 448 | 0–3 |
| Neutrophil count (cells/μL) | 36 | 0–3 |
| Total protein (mg/dL) | 788 | 10–40 |
| Glucose (mg/dL) | 111 | 50–75 |
| HSV antibody titer (CFT) | Negative | Negative |
| HSV-DNA (PCR) (copies/mL) | Negative | Negative |
| VZV antibody titer (CFT) | 4 | Negative |
| VZV-DNA (PCR) (copies/mL) | 1.4 × 106 | Negative |
CFT: Complement fixation test; HSV: Herpes simplex virus; PCR: Polymerase chain reaction; VZV: Varicella-zoster virus.
Figure 3Axial diffusion-weighted magnetic resonance imaging on day 3 and sagittal contrast-enhanced T1-weighted magnetic resonance imaging on day 14. A: The images show hyperintensities in the bilateral frontal lobes (block); B: Diffuse enhancement of meninges (arrows) with lumbar predominance and no cord enhancement.
The patient’s clinical course
|
|
|
|
|
|
| CSF cell count (cells/μL) | 484 | 112 | 119 | 29 |
| CSF VZV antibody titer (CFT) | 4 | 32 | ||
| CSF VZV-DNA (PCR) (copies/mL) | 1.4 × 106 | 3.2 × 102 | (-) | (-) |
| Serum VZV-IgM (EIA) | 0.49 (-) | 0.95 (±) | 0.44 (-) | |
| Serum VZV-IgG (EIA) | 75.9 (+) | > 128 (+) | > 128 (+) |
CSF: Cerebrospinal fluid; VZV: Varicella-zoster virus; CFT: Complement fixation test; PCR: Polymerase chain reaction; IgM: Immunoglobulin M; EIA: Enzyme immunoassay; IgG: Immunoglobulin G.
Summary of studies on VZV-associated meningitis, encephalitis, and myelitis
|
|
|
|
|
|
|
|
|
|
| 1 | Mancardi (1987) | 8 | 32 | F | None | None | Acyclovir | Survived |
| 2 | Kleinschmidt-DeMasters (1996) | 9 | 69 | F | Steroid dependent asthma | C8-Th3 distribution zoster | Not reported | Died |
| 3 | Kleinschmidt-DeMasters (1996) | 9 | 36 | M | HIV | None | Not reported | Died |
| 4 | Cinque (1997) | 10 | Not reported | Not reported | HIV | None | Acyclovir | Died |
| 5 | Sissoko (1998) | 11 | 75 | M | None | None | Acyclovir | Survived |
| 6 | Russman (2003) | 12 | 51 | F | Steroid dependent CREST syndrome | None | Acyclovir | Survived |
| 7 | Tavazzi (2008) | 13 | 85 | F | None | None | Acyclovir | Died |
| 8 | Tizazu (2020) | 14 | 53 | F | Steroid dependent SLE | None | Acyclovir | Survived |
| 9 | Takami (2021) | Present case | 64 | M | Mild diabetes mellitus | Four sporadic blisters | Acyclovir | Survived |
HIV: Human immunodeficiency virus; SLE: Systemic lupus erythematosus; F: Female; M: Male.